May 23, 2023, Legend Biotech Corporation (NASDAQ: LEGN) trading session started at the price of $68.42, that was -3.51% drop from the session before. During the day, the shares moved up to $68.81 and dropped to $66.32 before settling in for the closing price of $68.96. A 52-week range for LEGN has been $37.30 – $73.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 37.70% over the past five years. When this article was written, the company’s average yearly earnings per share was at 2.10%. With a float of $168.20 million, this company’s outstanding shares have now reached $170.54 million.
Let’s look at the performance matrix of the company that is accounted for 1390 employees. In terms of profitability, gross margin is +28.42, operating margin of -391.48, and the pretax margin is -380.94.
Legend Biotech Corporation (LEGN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Legend Biotech Corporation stocks. The insider ownership of Legend Biotech Corporation is 1.42%, while institutional ownership is 38.80%.
Legend Biotech Corporation (LEGN) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted -$0.68 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.78) by $0.1. This company achieved a net margin of -381.48 while generating a return on equity of -59.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.10% per share during the next fiscal year.
Legend Biotech Corporation (NASDAQ: LEGN) Trading Performance Indicators
You can see what Legend Biotech Corporation (LEGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 108.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.28, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -2.45 in one year’s time.
Technical Analysis of Legend Biotech Corporation (LEGN)
Legend Biotech Corporation (NASDAQ: LEGN) saw its 5-day average volume 0.56 million, a negative change from its year-to-date volume of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 25.13%. Additionally, its Average True Range was 2.87.
During the past 100 days, Legend Biotech Corporation’s (LEGN) raw stochastic average was set at 77.76%, which indicates a significant increase from 18.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.23% in the past 14 days, which was lower than the 52.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $58.33, while its 200-day Moving Average is $50.37. Nevertheless, the first resistance level for the watch stands at $68.13 in the near term. At $69.71, the stock is likely to face the second major resistance level. The third major resistance level sits at $70.62. If the price goes on to break the first support level at $65.64, it is likely to go to the next support level at $64.73. Assuming the price breaks the second support level, the third support level stands at $63.15.
Legend Biotech Corporation (NASDAQ: LEGN) Key Stats
There are 165,067K outstanding shares of the company, which has a market capitalization of 11.22 billion. As of now, sales total 117,010 K while income totals -446,350 K. Its latest quarter income was 36,340 K while its last quarter net income were -112,100 K.
